Clinical Trial Update: SGLT2 Inhibition and Stimulation of Endogenous Glucose Production: Protocol 2 [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update on SGLT2 inhibition and stimulation of endogenous glucose production in type 2 diabetes; study completed with results posted in 20…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Snippet

Sponsor: The University of Texas Health Science Center at San Antonio | Conditions: Type II Diabetes Mellitus | Phase 3 | Status: COMPLETED | Results posted: 2019-12-18